On the path to FDA

Founded in Austin, Texas

First patent issued.

Mobile RadBox prototype built

Core technology developed on a flexible platform

U.S. utility patent filed

EU utility patent filed

FDA De Novo designation granted

Second U.S. utility patent filed

Second EU utility patent filed

Plug and Play MedTech cohort; A-LIST finalist

Pathway to FDA submission defined

Hierarchy testing, lethality tests and full GLP validation.

Patents allowed in the U.S. and EU

Next-generation RB-Z1 built

FDA Q-Sub meeting #5

FDA concurred with the test organism panel and carriers.

Presented at IUVA Americas